NEWSROOM
News & Stories
Newsroom
Press Releases
Agendia Announces New Agreement with Daiichi Sankyo to Support Oncology Drug Development
Companies Will Apply Agendia Oncology Biomarker Expertise to Daiichi Sankyo Pharmaceutical Research IRVINE, CA and AMSTERDAM, April 24, 2014 – Agendia today announced a new agreement with Daiichi Sankyo regarding oncology drug development and personalized Read More
Agendia Announces New Data at European Breast Cancer Conference that Further Supports Use of MammaPrint and BluePrint Tests
Presentation Shows MammaPrint Can Accurately Stratify Recurrence Risk up to 25 Years IRVINE, CA and AMSTERDAM, March 26, 2014 – Four scientific presentations at the 9th European Breast Cancer Conference (EBCC) underscored the international scope Read More
Agendia Co-Founder Awarded EU Prize for Women Innovators
Laura van ‘t Veer, Ph.D., Honored as Inventor of MammaPrint Breast Cancer Test IRVINE, CA and AMSTERDAM, March, 10, 2014 – Agendia co-founder Laura van ‘t Veer, Ph.D., has been awarded a 2014 Read More







